Found: 6
Select item for more details and to access through your institution.
Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1826, doi. 10.3390/vaccines11121826
- By:
- Publication type:
- Article
Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15 , 1252.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 6, p. 1252, doi. 10.3390/v15061252
- By:
- Publication type:
- Article
Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.926929
- By:
- Publication type:
- Article
Human Superantibodies to 3CL pro Inhibit Replication of SARS-CoV-2 across Variants.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6587, doi. 10.3390/ijms23126587
- By:
- Publication type:
- Article
Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase.
- Published in:
- Molecules, 2021, v. 26, n. 21, p. 6436, doi. 10.3390/molecules26216436
- By:
- Publication type:
- Article